Search Results - "Elbadry, Mahmoud I"

Refine Results
  1. 1

    Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study by Esmaeel, Hend M., Ahmed, Heba A., Elbadry, Mahmoud I., Khalaf, Asmaa R., Mohammed, Nesreen A., Mahmoud, Hamza A., Taha, Elhaisam M.

    Published in Scientific reports (01-08-2022)
    “…There has been growing attention toward the predictive value of the coagulation parameters abnormalities in COVID-19. The aim of the study was to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Induced pluripotent stem cell technology: A window for studying the pathogenesis of acquired aplastic anemia and possible applications by Elbadry, Mahmoud I, Espinoza, J. Luis, Nakao, Shinji

    Published in Experimental hematology (01-05-2017)
    “…Recent progress in human induced pluripotent stem cells (iPSCs) has opened the door to a better understanding of the biology of human diseases, especially rare…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Selective immunoglobulin M deficiency in an adult with miliary tuberculosis: A clinically interesting coexistence. A case report and review of the literature by Hassanein, Hassan A, Elbadry, Mahmoud I

    Published in International journal of mycobacteriology (01-03-2016)
    “…Abstract Selective immunoglobulin M (SIgM) deficiency is a rare form of dysgammaglobulinemia. Here we are reporting a 31 year old man with multiple cervical…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Disease modeling of bone marrow failure syndromes using iPSC-derived hematopoietic stem progenitor cells by Elbadry, Mahmoud I., Espinoza, J. Luis, Nakao, Shinji

    Published in Experimental hematology (01-03-2019)
    “…•Induced pluripotent stem cells (iPSCs) can be generated from patients with bone marrow failure syndromes (BMFSs).•Patient-derived iPSCs can generate…”
    Get full text
    Journal Article
  11. 11

    CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia by Ahmed, Heba A., Nafady, Asmaa, Ahmed, Eman H., Hassan, Emad Eldin Nabil, Soliman, Walaa Gamal Mohamed, Elbadry, Mahmoud I., Allam, Ahmed Ahmed

    Published in Annals of hematology (01-03-2024)
    “…The clinical outcome of lymphocytic leukemia (CLL) is quite heterogeneous. The purpose of this observational study was to investigate the clinical merit of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia by Espinoza, J. Luis, Elbadry, Mahmoud I, Taniwaki, Masafumi, Harada, Kenichi, Trung, Ly Quoc, Nakagawa, Noriharu, Takami, Akiyoshi, Ishiyama, Ken, Yamauchi, Takuji, Takenaka, Katsuto, Nakao, Shinji

    Published in Cancer letters (01-08-2017)
    “…Abstract Acute myelogenous leukemia (AML) is a clinically heterogeneous disease that is frequently associated with relapse and a poor prognosis. Among the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Venous Thromboembolism Risk Assessment among Beta-thalassemia Patients by Abo-Elwafa, Hasnaa A., Youseff, Laila M., Mahmoud, Ramadan A., Elbadry, Mahmoud I., Tawfeek, Ahmed, Aziz, Shereen P.

    Published in Journal of Applied Hematology (01-07-2023)
    “…BACKGROUND: Thromboembolic (TE) disorders are among the most common complications of beta-thalassemia. We designed this cross-sectional study to investigate…”
    Get full text
    Journal Article
  20. 20